Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo Nordisk becomes diabetes drug sales leader

Novo Nordisk becomes diabetes drug sales leader Novo's success has come from the strength of its diabetes brands, with type II diabetes injection Victoza(liraglutide) up 15% last year, with sales hitting $2bn. ... The firm also has high hopes in its new obesity drug Saxenda - which is essentially a

Novo brings Xultophy to third European market

Novo brings Xultophy to third European market Xultophy combines Novo's blockbuster GLP-1 receptor agonist Victoza (liraglutide) with its new long-acting insulin Tresiba (insulin degludec) in a once-daily injection for type 2 diabetes. ... We do see that some patients that have been on both an

Rivals look to put pressure on Sanofi's Lantus

Rivals look to put pressure on Sanofi's Lantus One of those with Lantus in its sights is Novo Nordisk, whose Xultophy combination of Tresiba (insulin degludec) and Victoza (liraglutide) was pitted against Lantus in the DUAL V study. ... It saw adults, whose type 2 diabetes was uncontrolled on 20-50

Transition takes on Lilly muscle-boosting drug

Transition takes on Lilly muscle-boosting drug TT401 is a GLP-1 dual agonist that Transition believes will show superior glucose control compared to current GLP-1 drugs such as Novo Nordisk's Victoza (liraglutide), and is the

Saxenda debuts in US with $1,000-a-month price tag

Saxenda debuts in US with $1,000-a-month price tag Saxenda (liraglutide) is a high-dose version of Novo Nordisk's diabetes therapy Victoza and was approved by the FDA towards the end of last year. ... Analysts said the price was expected given the cost of Victoza is around $500 per month without

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...